Jean M. Dostou

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.

Christian Meyer, Michael Stümvoll, Veena Nadkarni et al. · Journal of Clinical Investigation · 1998 · 299 citations · Full text

Renal Pathology, Abnormal Renal, Metabolic Syndrome +19

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

Mark Rigby, Kristina M. Harris, Ashley Pinckney et al. · Journal of Clinical Investigation · 2015 · 286 citations · Full text

Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis

Christian Meyer, Jean M. Dostou, Stephen Welle et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 266 citations

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

Mark Rigby, Linda A. DiMeglio, Marc Rendell et al. · The Lancet Diabetes & Endocrinology · 2013 · 201 citations · Full text

Memory T Cells, Autoimmune Disease, Diabetes +9

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Matthias von Herrath, Stephen C. Bain, Bruce W. Bode et al. · The Lancet Diabetes & Endocrinology · 2021 · 163 citations · Full text

Inflammation, β-Cell Function, Diabetes Management +7